2 completed, 2 unknown, 1 terminated. 2 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 4 | 1 | Unknown 1 |
Follow bucillamine: new trials by email Literature Review of bucillamine trials Research Report on bucillamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bucillamine in Treatment of Patients With COVID-19 Bucillamine, Placebo - Covid19 | Phase 3 | Terminated | Revive Therapeutics, Ltd. | 713 | 2020-11-27 | 2023-07-07 |
| Bucillamine Phase 2 Trial in Patients With Cystinuria Bucillamine - Cystinuria | Phase 2 | Unknown | Revive Therapeutics, Ltd. | 30 | 2017-05-01 | 2017-05-18 |
| Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout Bucillamine, Colchicine - Gout | Phase 2 | Completed | Revive Therapeutics, Ltd. | 66 | 2015-04-01 | 2016-10-05 |
| A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA) Sarilumab, Sulfasalazine, Leflunomide - Rheumatoid Arthritis | Phase 3 | Completed | Sanofi | 91 | 2015-02-01 | 2018-01-30 |
| Bucillamine Study of Holding Remission After Infliximab Dose-off bucillamine, methotrexate - Rheumatoid Arthritis | Phase 4 | Unknown | Saitama Medical University | 40 | 2007-01-01 | 2011-01-05 |
Arthritis, Rheumatoid (2) · COVID-19 (1) · Cystinuria (1) · Gout (1)
Revive Therapeutics, Ltd. (3) · Saitama Medical University (1) · Sanofi (1)
United States (3) · Japan (2) · Puerto Rico (1)